Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP in Elderly Patients After Total Knee Arthroplasty

NCT ID: NCT05572307

Last Updated: 2023-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-30

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single-celled sequencing for evaluating differences in gene expression patterns in different cell types of the dynamics of a means of this research as a starting point, to study the postoperative delirium and chronic pain at the cellular level changes the contents of a cell, reveal its occurrence and development of the role of gene regulation, find targets and biomarkers, and to provide new ideas for its pathogenesis, To provide theoretical basis support for its prevention, clinical diagnosis and treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study was to investigate leukocyte heterogeneity in patients undergoing total knee arthroplasty with POD, paired non-POD patients, and cognitively normal healthy subjects by single cell sequencing, and to investigate leukocyte heterogeneity in patients with chronic pain and patients with pain relief after surgery through postoperative pain follow-up. Moreover, multi-omics single cell technology is used to analyze various cellular contents in a single cell simultaneously, which can capture molecular footprints with higher resolution. Comprehensive analysis of multiple omics datasets reveals the relationships between cellular patterns, establishes complex regulatory networks, and provides a holistic view of cellular state. From a single cell level analysis of POD and occurred in patients with chronic pain in patients with the characteristics of the white blood cells, looking for the peripheral immune system in the pathogenesis of the POD and the potential role of chronic pain occurs, may provide POD pathogenesis and chronic pain occurred an important visual Angle, may also help to provide POD biomarkers and therapeutic targets, To provide a possible solution for the prevention and treatment of postoperative delirium and postoperative chronic pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Delirium Chronic Postsurgical Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

POD group

According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

No interventions assigned to this group

non-POD group

According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

No interventions assigned to this group

CPSP group

Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain

No interventions assigned to this group

non-CSP group

Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥65 years old, regardless of gender.
* total knee arthroplasty for the first time.
* The ASA classification is I-Ⅲ.

Exclusion Criteria

* severe neurological or psychiatric disorders
* drug and alcohol abuse
* patients on antidepressants
* failure and decompensation of vital organs
* chronic pain from previous surgery or trauma
Minimum Eligible Age

65 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Affiliated Hospital of Xuzhou Medical University

OTHER

Sponsor Role collaborator

Xuzhou Central Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yangzi Zhu, Doctor

Role: PRINCIPAL_INVESTIGATOR

Xuzhou Central Hospital

Liwei Wang, Doctor

Role: STUDY_DIRECTOR

Xuzhou Central Hospital

Junli Cao, Doctor

Role: STUDY_DIRECTOR

Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University

Daqing Ma, Doctor

Role: STUDY_CHAIR

Imperial College London, Chelsea and Westminster Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xuzhou Central Hospital

Xuzhou, Jiangsu, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yangzi Zhu, Doctor

Role: CONTACT

+86 18168779150

Liwei Wang, Doctor

Role: CONTACT

+86 18952170255

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yangzi Zhu, Doctor

Role: primary

+86 18168779150

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XuzhouCH20221010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.